Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease. The research by a team of Emory University scientists will be published June 18 in the Public Library of Science Biology (PLoS Biology) journal.
